Organization: Health Canada
Year: 2024
Month: September
Request Number: A-2023-001333
Request Summary: Adverse Drug Reactions (ADRs) for Ondansetron. Report numbers: E2B_06719295, E2B_06758044. ADR for Pantoloc. Report number: 001066050. ADRs for Pantoprazole sodium. Report numbers: E2B_06731244, E2B_06741613. ADRs for Tecta. Report numbers: E2B_06757633, E2B_06712065. ADRs for MEZAVANT. Report numbers: 001070662, E2B_06753460. ADR for Mesalamine. Report number: E2B_06726864.
Disposition: Disclosed in part
Number of pages: 1885